StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3025% above fair value
$232.23−4.75 (-2.00%)

Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –

Danaher Biotechnology by Quarter

Biotechnology — Depreciation % of Segment Sales (MD&A) (%)

QuarterlyAnnual

Danaher Biotechnology: 2.4% in Q3 2026, up 0.3 pts from a year earlier.

Latest, Q3 2026
2.4%
Period ended Sep 30, 2026
Change on a year earlier
+0.3 pts
2.1% in Q3 2025
History
15 quarters
Since Q1 2022
Sources
12
Documents cited below

Where the Q3 2026 figure comes from

Source: Danaher SEC 10-Q (2026Q3, filed 2026-10-21) ↗

Reported for Q1, Q2, Q3 (10-Q) and full year (10-K), with no standalone Q4 reported.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBiotechnology — Depreciation % of Segment Sales (MD&A) (%)Year on yearSource
Q3 2026Sep 30, 20262.4%+0.3 ptsDanaher SEC 10-Q (2026Q3, filed 2026-10-21) ↗
Q2 2026Jun 30, 20262.1%0.0 ptsDanaher SEC 10-Q (2026Q2, filed 2026-07-21) ↗
Q1 2026Mar 31, 20262.2%+0.1 ptsDanaher SEC 10-Q (2026Q1, filed 2026-04-21) ↗
Q3 2025Sep 30, 20252.1%-0.1 ptsDanaher SEC 10-Q (2025Q3, filed 2025-10-21) ↗
Q2 2025Jun 30, 20252.1%+0.1 ptsDanaher SEC 10-Q (2025Q2, filed 2025-07-22) ↗
Q1 2025Mar 31, 20252.1%-0.7 ptsDanaher SEC 10-Q (2025Q1, filed 2025-04-22) ↗
Q3 2024Sep 30, 20242.2%-0.2 ptsDanaher SEC 10-Q (2024Q3, filed 2024-10-22) ↗
Q2 2024Jun 30, 20242.0%-0.1 ptsDanaher SEC 10-Q (2024Q2, filed 2024-07-23) ↗
Q1 2024Mar 31, 20242.8%+0.7 ptsDanaher SEC 10-Q (2024Q1, filed 2024-04-23) ↗
Q3 2023Sep 30, 20232.4%+0.5 ptsDanaher SEC 10-Q (2023Q3, filed 2023-10-24) ↗
Q2 2023Jun 30, 20232.1%+0.2 ptsDanaher SEC 10-Q (2023Q2, filed 2023-07-25) ↗
Q1 2023Mar 31, 20232.1%+0.1 ptsDanaher SEC 10-Q (2023Q1, filed 2023-04-25) ↗
Q3 2022Sep 30, 20221.9%–Danaher SEC 10-Q (2023Q3, filed 2023-10-24) ↗
Q2 2022Jun 30, 20221.9%–Danaher SEC 10-Q (2023Q2, filed 2023-07-25) ↗
Q1 2022Mar 31, 20222.0%–Danaher SEC 10-Q (2023Q1, filed 2023-04-25) ↗

Cite this data

StockData. (2026). Danaher Biotechnology (%), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/mda-depr-pct-sales-biotech

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.